Back to search
FDAFDA · Food and drugs·Recall number D-1413-2020

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

Published August 5, 2020 · Recall initiated: July 17, 2020

Summary

FDA records drug Class II recall D-1413-2020, published August 5, 2020 and initiated July 17, 2020. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 11,688 bottles; Lot: Lot # Q000232, exp. date 01/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

What to do

Voluntary: Firm initiated · Letter

Get an email if LISINOPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISINOPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed to OH and may have been further distributed throughout the United States.
UPC
0368001334082
Lot
Lot # Q000232, exp. date 01/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08 recalled?

Yes. FDA published recall D-1413-2020 on August 5, 2020. Reported hazard: Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISINOPRIL. UPC: 0368001334082.